Performance of Amino Acid PET in Brain Metastases
ConditionPET-CT
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorCentral Hospital, Nancy, France
About this trial
Differentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications
Eligibility criteria
Qualifiers
Patients who received a PET amino acid for differentiating radiation necrosis from progression of irradiated brain metastases,
Disqualifiers
Patients who refused the using of their data
Trial design
Treatments tested in this trial
- PET exam analysis
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov